STAT3 and lung carcinoma: These results combined with protein array demonstrated that CAF may regulates lung cancer resistance through the STAT3/MMP signaling pathway, and inhibition of STAT3 in CAF can block the secretion of MMP which induce osimertinib resistance in lung cancer cells.